TY - CONF
T1 - IS PASI 90-100 THE MOST IMPORTANT GOAL FOR DEFINING THE CHOICE OF IMMUNOBIOLOGICAL IN MODERATE TO SEVERE PSORIATIC DISEASE? FOLLOW UP OF A MIXED POPULATION FOR 17 YEARS
JO - Blucher Medical Proceedings
VL - 1
IS - 5
SP - 489
EP - 489
PY - 2019
T2 - 36º Congresso Brasileiro de Reumatologia
AU - , , 

SN - 23577282
DO - http://dx.doi.org/10.5151/sbr2019-489
UR - www.proceedings.blucher.com.br/article-details/is-pasi-90-100-the-most-important-goal-for-defining-the-choice-of-immunobiological-in-moderate-to-severe-psoriatic-disease-follow-up-of-a-mixed-population-for-17-years-32981
KW - 
ER -